PsychoGenics Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:PsychoGenics Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013226
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PsychoGenics Inc (PsychoGenics) is an preclinical contract research organization that offers contract research, standard and customized preclinical services and drug discovery services. The organization offers various behavioral tests to drug candidates in the areas of pain and inflammation, psychiatric and neurodegenerative disorders, and spinal cord and traumatic brain injury. Its phenocube is used to identify compounds with potential to treat cognitive impairment. PsychoGenics offers behavioral testing, electrophysiology, microdialysis, and other services. The organization caters to biotechnology, pharmaceutical, and other sectors. PsychoGenics is headquartered in Tarrytown, New York, the US.

PsychoGenics Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PsychoGenics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Resilience Therapeutics Enters into Drug Discovery Agreement with PGI 10
PGI Drug Discovery And Roche Expand Drug Discovery Agreement 11
PsychoGenics Extends Drug Discovery Agreement with Sunovion Pharma 12
Afraxis And PsychoGenics Enter Into Partnership To Offer Afraxis’ ESP Technology For Drug Discovery 13
PsychoGenics Enters Into Joint Venture Agreement With KineMed 14
Licensing Agreements 15
PsychoGenics Enters into Licensing Agreement with University of California, San Diego 15
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine for Transgenic Mouse Model of a-Synucleinopathies 16
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine 17
PsychoGenics Enters into Licensing Agreement with McGill University for McGill-R-Thy I-APP 18
PsychoGenics Enters into Licensing Agreement with Yeda Research and Development 19
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 20
Amarantus Enters Into Licensing Agreement With PGI Drug Discovery For Eltoprazine 21
PsychoGenics Enters Into Licensing Agreement With University of South Florida For APP/PS1 Transgenic Mouse Model 22
PsychoGenics Inc – Key Competitors 23
PsychoGenics Inc – Key Employees 24
PsychoGenics Inc – Locations And Subsidiaries 25
Head Office 25
Recent Developments 26
Other Significant Developments 26
Jan 19, 2016: PsychoGenics Expands its Drug Discovery Service Capabilities 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
PsychoGenics Inc, Pharmaceuticals & Healthcare, Key Facts 2
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PsychoGenics Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PsychoGenics Inc, Deals By Therapy Area, 2011 to YTD 2017 8
PsychoGenics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Resilience Therapeutics Enters into Drug Discovery Agreement with PGI 10
PGI Drug Discovery And Roche Expand Drug Discovery Agreement 11
PsychoGenics Extends Drug Discovery Agreement with Sunovion Pharma 12
Afraxis And PsychoGenics Enter Into Partnership To Offer Afraxis' ESP Technology For Drug Discovery 13
PsychoGenics Enters Into Joint Venture Agreement With KineMed 14
PsychoGenics Enters into Licensing Agreement with University of California, San Diego 15
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine for Transgenic Mouse Model of a-Synucleinopathies 16
PsychoGenics Enters into Licensing Agreement with University of California, San Diego School of Medicine 17
PsychoGenics Enters into Licensing Agreement with McGill University for McGill-R-Thy I-APP 18
PsychoGenics Enters into Licensing Agreement with Yeda Research and Development 19
PsychoGenics Enters Into Licensing Agreement With Mayo Clinic And TET Systems For rTg4510 Tauopathy Mouse Model 20
Amarantus Enters Into Licensing Agreement With PGI Drug Discovery For Eltoprazine 21
PsychoGenics Enters Into Licensing Agreement With University of South Florida For APP/PS1 Transgenic Mouse Model 22
PsychoGenics Inc, Key Competitors 23
PsychoGenics Inc, Key Employees 24

★海外企業調査レポート[PsychoGenics Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ESI Group S.A. (ESI):企業の財務・戦略的SWOT分析
    ESI Group S.A. (ESI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Cancer Genetics Inc (CGIX):企業の財務・戦略的SWOT分析
    Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that provides diagnostics products and services in oncology areas. The company offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. Its oncology tests and laboratory services offer critical genomic info …
  • MegaChips Corp (6875):企業の財務・戦略的SWOT分析
    MegaChips Corp (6875) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Fugro NV (FUR):企業の財務・戦略的SWOT分析
    Fugro NV (FUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Yamato Holdings Co Ltd (9064):企業の財務・戦略的SWOT分析
    Yamato Holdings Co Ltd (9064) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Meridian Bioscience Inc (VIVO):企業の財務・戦略的SWOT分析
    Meridian Bioscience Inc (VIVO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Schnell Biopharmaceuticals Inc (003060)-製薬・医療分野:企業M&A・提携分析
    Summary Schnell Biopharmaceuticals Inc (Schnell), formerly Korea Schnell Pharma Co., Ltd. is a healthcare company that offers agents and antibiotics. The company provides pharmaceutical products including amino acid infusion agents and antibiotics. Its products portfolio includes antibiotics, infusi …
  • University of New Mexico-製薬・医療分野:企業M&A・提携分析
    Summary University of New Mexico (UNM) is an educational service provider that offers bachelors, masters, doctoral and professional degree programs in various fields. The university offers programs such as continuing education, evening and weekend degree programs, extended learning and Latin America …
  • JEA:企業の発電所・SWOT分析2018
    JEA - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (executives), a …
  • Essentra plc (ESNT):企業の財務・戦略的SWOT分析
    Essentra plc (ESNT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • AcuFocus Inc:医療機器:M&Aディール及び事業提携情報
    Summary AcuFocus Inc (AcuFocus) is an ophthalmic medical device company that develops and markets technologies for the improvement of near vision. The company develops and markets breakthrough technologies for the improvement of vision. It’s IC-8 IOL, a small aperture lens that is designed for preby …
  • Panoptes Pharma GesmbH:製薬・医療:M&Aディール及び事業提携情報
    Summary Panoptes Pharma GesmbH (Panoptes Pharma) is a biotech company that develops small molecule based therapies to treat severe eye diseases. The company also develops products in the therapeutic areas of uveitis, viral conjunctivitis, and further indications. It concentrates on a new treatment f …
  • AOL Inc:企業の戦略的SWOT分析
    AOL Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Stem Inc:電力:M&Aディール及び事業提携情報
    Summary Stem, Inc. (Stem) is a provider of energy storage solutions and software to businesses for managing energy costs. It leverages big data, predictive analytics, cloud computing, and advanced energy storage to reduce peak electrical usage, lower electric bills, and eliminate the need for new ge …
  • E. & J. Gallo Winery:企業の戦略・SWOT・財務情報
    E. & J. Gallo Winery - Strategy, SWOT and Corporate Finance Report Summary E. & J. Gallo Winery - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Eizo Corp (6737):企業の財務・戦略的SWOT分析
    Eizo Corp (6737) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • NCsoft Corporation (036570):企業の財務・戦略的SWOT分析
    NCsoft Corporation (036570) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • CryoTherapeutics Gmbh:医療機器:M&Aディール及び事業提携情報
    Summary CryoTherapeutics GmbH (CryoTherapeutics) is a medical equipment company that offers systemic drug based approach in combination with a localised device-based therapy. The company offers proprietary cryotherapy system that used for the treatment of coronary artery disease that causes heart at …
  • Amedica Corp (AMDA):医療機器:M&Aディール及び事業提携情報
    Summary Amedica Corp (Amedica) is a biomaterial company that develops, produces and markets medical-grade silicon nitride ceramics for spinal implants and arthroplasty applications. The company offers interbody fusion devices, pedicle screw systems, facet fixation systems. It also offers non-silicon …
  • SK Telecom Co., Ltd.:企業の戦略・SWOT・財務分析
    SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary SK Telecom Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆